Article Details

ArriVent BioPharma Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

Retrieved on: 2024-07-09 21:18:23

Tags for this article:

Click the tags to see associated articles and topics

ArriVent BioPharma Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits. View article details on hiswai:

Excerpt

8-K/A - ArriVent BioPharma, Inc. (0001868279) (Filer)

Article found on: quantisnow.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo